Analysis of Lipids in Human Milk at Different Gestational Ages
Essential Long-chain Polyunsaturated Fatty Acids Quantitation in Breast Milk Samples at Different Gestational Ages
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Giuseppe De Bernardo, MD
- Phone Number: 3357441303
- Email: pinodebtin@gmail.com
Study Locations
-
-
-
Napoli, Italy, 80123
- Recruiting
- Department of Woman and Child, Buon Consiglio Fatebenefratelli Hospital
-
Contact:
- Giuseppe De Bernardo
- Phone Number: 3357441303
- Email: pinodebtin@gmail.com
-
Principal Investigator:
- Giuseppe De Bernardo, MD
-
Sub-Investigator:
- Maurizio Giordano, Dr
-
Sub-Investigator:
- Giuseppina Leone, MD
-
-
Naples
-
Salerno, Naples, Italy, 84084
- Recruiting
- Department of Pharmacy, University of Salerno
-
Contact:
- Pietro Campiglia, Prof
- Email: pcampiglia@unisa.it
-
Sub-Investigator:
- Pietro Campiglia, Prof
-
Sub-Investigator:
- Giacomo Pepe, Prof
-
Sub-Investigator:
- Manuela Giovanna Basilicata, Dr
-
Sub-Investigator:
- Emanuela Salviati, PhD
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Mothers who have given birth in hospital at any gestational age
- Written informed consent
- BMI 18.50-24.99 Kg/m2
- Varied and balanced maternal diet without restrictions
- Weight gain during pregnancy up to 12kg
Exclusion Criteria:
- Food intolerance
- Celiac disease
- Vegan or vegetarian diet
- Diet with the exclusion of milk and derivatives
- Diagnosis of metabolic diseases
- Taking medicines during pregnancy
- Withdrawal of informed consent
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Women < 32 weeks of gestational age
Women that delivered before 32 weeks of gestational age
|
Mothers will breastfeed their newborns
|
|
Women between 32 and 36,6 weeks of gestational age
Women that delivered between 32 and 36,6 weeks of gestational age
|
Mothers will breastfeed their newborns
|
|
Women > 37 weeks of gestational age
Women that delivered after 37 weeks of gestational age
|
Mothers will breastfeed their newborns
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quantification of essential long-chain polyunsaturated fatty acids in human milk
Time Frame: 7 days after delivery
|
To assess the concentrations of α-Linoleic acid (µg/mL) in human milk
|
7 days after delivery
|
|
Quantification of essential long-chain polyunsaturated fatty acids in human milk
Time Frame: 7 days after delivery
|
To assess the concentrations of Eicosapentaenoic acid (µg/mL) in human milk
|
7 days after delivery
|
|
Quantification of essential long-chain polyunsaturated fatty acids in human milk
Time Frame: 7 days after delivery
|
To assess the concentrations of Docosahexaenoic acid (µg/mL) in human milk
|
7 days after delivery
|
|
Quantification of essential long-chain polyunsaturated fatty acids in human milk
Time Frame: 7 days after delivery
|
To assess the concentrations of Arachidonic acid (µg/mL) in human milk
|
7 days after delivery
|
|
Quantification of essential long-chain polyunsaturated fatty acids in human milk
Time Frame: 7 days after delivery
|
To assess the concentrations of Linoleic acid (µg/mL) in human milk
|
7 days after delivery
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quantification of essential long-chain polyunsaturated fatty acids in human milk
Time Frame: 1 month after delivery
|
To assess the concentrations of α-Linoleic acid (µg/mL) in human milk
|
1 month after delivery
|
|
Quantification of essential long-chain polyunsaturated fatty acids in human milk
Time Frame: 1 month after delivery
|
To assess the concentrations of Eicosapentaenoic acid (µg/mL) in human milk
|
1 month after delivery
|
|
Quantification of essential long-chain polyunsaturated fatty acids in human milk
Time Frame: 1 month after delivery
|
To assess the concentrations of Docosahexaenoic acid (µg/mL) in human milk
|
1 month after delivery
|
|
Quantification of essential long-chain polyunsaturated fatty acids in human milk
Time Frame: 1 month after delivery
|
To assess the concentrations of Arachidonic acid (µg/mL) in human milk
|
1 month after delivery
|
|
Quantification of essential long-chain polyunsaturated fatty acids in human milk
Time Frame: 1 month after delivery
|
To assess the concentrations of Linoleic acid (µg/mL) in human milk
|
1 month after delivery
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Giuseppe De Bernardo, MD, Ospedale Buon Consiglio Fatebenefratelli
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
Other Study ID Numbers
- 1669
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.